0000000000503512

AUTHOR

Isajevs Sergejs

showing 1 related works from this author

Multicentric randomised study of

2017

Introduction Population-based eradication of Helicobacter pylori has been suggested to be cost-effective and is recommended by international guidelines. However, the potential adverse effects of widespread antibiotic use that this would entail have not been sufficiently studied. An alternative way to decrease gastric cancer mortality is by non-invasive search for precancerous lesions, in particular gastric atrophy; pepsinogen tests are the best currently available alternative. The primary objective of GISTAR is to determine whether H pylori eradication combined with pepsinogen testing reduces mortality from gastric cancer among 40–64-year-old individuals. The secondary objectives include ev…

AdultMalePepsinogenHelicobacter InfectionsStomach NeoplasmsPepsinogen AGastroscopyProtocolHumans17241506MortalityEradicationHelicobacter pylori1695Randomised StudyPreventionStomachMiddle Aged1692Anti-Bacterial AgentsEuropeGastric CancerResearch DesignFemalePublic HealthH. Pylori1717Precancerous ConditionsBMJ open
researchProduct